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doi:10.1016/j.fjs.2012.02.001Summary Substernal goiter can be classified as primary or secondary, depending on the site
of origin. Primary substernal goiters (< 1% of substernal goiters), also known as mediastinal
aberrant goiters, arise from ectopic thyroid tissue in the mediastinum, and receive their blood
supply from intrathoracic arteries instead of thyroid arteries. A secondary substernal goiter is
defined as one that has descended from the neck to the plane below the thoracic inlet, or one
that has more than 50% of its mass lying inferior to the thoracic inlet. Surgical resection should
be considered even for elderly patients because of the risks of mass compression symptoms
(e.g., dyspnea and dysphasia), malignancy, and low morbidity of surgery. Most of the primary
substernal goiters can be resected through the cervical approach. In most instances, sternot-
omy or thoracotomy is needed only in cases of previous cervical thyroidectomy, invasive carci-
noma, or ectopic goiter.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
The term goiter has been defined as an enlargement of
thyroid gland, while some authors refer to a thyroid gland
that is enlarged to twice its normal size or weighs more
than about 40 g.1 Most of surgical goiters reported in the
literature were nonendemic, although the classic patho-
physiology of goiter development is dietary iodine defi-
ciency, which leads to hypothyroidism with an increase inHo Hospital, Number 291,
Taipei 235, Taiwan.
o.com.tw
ight ª 2012, Taiwan Surgical Assothyroid-stimulating hormone (TSH), and then causes
thyroid gland hypertrophy (so-called endemic goiters).
Substernal goiter was first described by Haller2 in 1749, and
Klein3 was credited with removing the first substernal goiter
in 1820. In addition to substernal goiter, there are other
synonyms, including ‘retrosternal,’ ‘intrathoracic,’ or
‘mediastinal’ goiters in the literature.2. Definitions and incidence
The terminology has not yet been standardized in the
literature, nor has the proportion of the thyroid gland
extending from the neck into the thorax been uniformlyciation. Published by Elsevier Taiwan LLC. All rights reserved.
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a substernal goiter as one that has descended below the
plane of the thoracic inlet or has more than 50% of its mass
lying inferior to the thoracic inlet.5e8 Other definitions of
substernal goiter consist of the following: the goiter with
a major intrathoracic component that requires reaching
into the mediastinum for its dissection, or if the goiter lies
two fingerbreadths inferior to the thoracic inlet in the
supine position, or if the goiter reaches the levels of the
aortic arch or T4 on chest radiography.9,10 Given these
myriad definitions, the incidence of substernal goiters as
a percentage of thyroidectomies varies substantially in the
literature, i.e., from 2%e19%.11 Based on a systematic
review of surgical managements and its complications, Huin
and colleagues12 defined a new classification system of
substernal goiters from Grade 1 to Grade 3 according to
their anatomic locations and the surgical approaches
(including cervical, manubriectomy, or full sternotomy
respectively).3. Anatomy and clinical features
Substernal goiters can be classified as primary or secondary,
depending on their sites of origin.13 Less than 1% of sub-
sternal goiters are thought to be truly primary in nature,
also known as mediastinal aberrant goiters, arising from
ectopic thyroid tissue in the mediastinum. These aberrant
goiters have no connection with the cervical thyroid gland
and receive their blood supply from intrathoracic arteries
instead of thyroid arteries. Secondary substernal goiters,
which develop owing to the downward growth of cervical
thyroid tissue, account for most cases. These goiters tend
to grow into two mediastinal regions: (a) the anterior
mediastinum, anterior to the recurrent laryngeal nerve
(RLN) and anterolateral to the trachea, and (b) the poste-
rior mediastinum (10%e15%), descending posterior to the
carotid sheath and the RLN, especially the right-side
posterior mediastinum (> 90%).14 Almost all of the
secondary substernal goiters, no matter anterior or poste-
rior in location, continue to receive their blood supply from
the superior and inferior thyroid arteries.
Generally, with female predominance, substernal
goiters tend to grow slowly, and commonly leading to
presentation in the fifth and sixth decades of life. In 20%e
30% of cases, the goiter is not palpable or is barely palpable
in the neck, with most of the tumor bulk in the chest.6 The
most common presenting symptoms are due to mass
compression effects, including (a) compression of the
airway (most frequent), inducing the symptoms from a mild
cough, upper respiratory tract infection, or isolated dysp-
nea to severe, life-threatening asphyxia, and (b) impinging
on other nearby structures (e.g., esophagus and vessels),
causing dysphagia, hoarseness, and other neurologic and
vascular symptoms.4,6 Frequent infections of various
degrees were the commonest clinical feature in our
previous series.4 Precipitating factors for acute and severe
respiratory distress may include a large substernal goiter
with intrathyroid bleeding or upper respiratory infections.
Although a few patients with substernal goiters may
present with thyrotoxicosis and weight loss, most of them
are in euthyroid status.4. Risks of malignancy
Risk factors for malignancy in substernal goiters may
include old age, a family history of thyroid pathology,
a history of cervical radiation therapy, recurrent goiter, and
the presence of cervical adenopathy, thrombotic material
within the lumen of a vein in contact with a substernal
goiter, and possible preoperative hoarseness. However, the
incidence of cancer in substernal goiters is no higher than
the incidence of cancer in cervical goiters; 25 series
reported malignancy in 0%e22.6% of substernal goiters in
literature review.11 The most common type of carcinoma
was papillary, followed by follicular, medullary, mixed or
coincident, and anaplastic. Most of the tumors (> 50%e60%)
are microcarcinoma (< 1 cm).15 However, the inability to
rule out malignancy in substernal goiters provides a further
rationale for performing total or subtotal thyroidectomy in
these cases.5. Diagnosis
With addition of pertinent clinical manifestations, sub-
sternal goiter is a major diagnostic consideration in evalu-
ating mass lesions in the upper mediastinal region. Neck
and chest radiography as well as computed tomography
(CT) scan and magnetic resonance imaging (MRI) are
essential for diagnosis. Typical radiography discloses a mass
with tracheal deviation or compression at and below the
thoracic inlet, calcification within the tumor, and reflection
of the mediastinal pleura below the goiter (Fig. 1A and B).
Erbil and colleagues16 reported that chest radiography
might provide the first evidence of a substernal goiter in
77% of patients. CT scanning can further permit detailed
evaluation of the intrathoracic extent of the thyroid (for
secondary substernal goiter) and displacement of the
trachea, esophagus, and regional vessels. MRI may provide
a critical tool in the visualization of tissue and local inva-
sion of vascular structures by the mass. Fine-needle aspi-
ration biopsy of substernal goiters for cytologic analysis
may be helpful when a large cervical component exists, but
this is not usually recommended because it can be
dangerous and the material obtained is often inadequate
for histologic diagnosis of malignancy. It is accepted that
thyroid radionuclide scans are not particularly helpful
although more than half of substernal extensions can be
detected on scintiscans.4 Nuclear thyroid imaging may
demonstrate thyroid activity in the mediastinum, but the
absence of uptake in the mediastinum does not exclude
a diagnosis of substernal goiter.166. Managements for substernal goiter
There is general agreement that medical treatment is
ineffective for substernal goiters; thyroxine suppression
and iodine-131 ablation are not particularly useful.17
Moreover, radioiodine therapy may induce acute inflam-
mation and swelling of the gland with the potential for
airway obstruction. The treatment of substernal disease is
clearly surgical, but there is no consensus on the indications
for thyroidectomy, although many authors suggest that
Figure 1 (A) The representative chest radiograph; and (B) chest CT scan of a giant substernal goiter. A woman 62 years of age was
admitted with acute respiratory distress. Chest radiograph and CT scan revealed a giant substernal goiter from the cervical region
to the level of tracheal carina with severe deviation and compression of the trachea and superior vena cava vein. Thyroidectomy
was smoothly performed through the cervical collar incision. Patient was uneventfully discharged on the fourth postoperative day.
CTZ computed tomography.
Surgery for substernal goiter 43thyroidectomy should be performed in all patients with
substernal goiter who do not have medical comorbidity
excluding them from surgery.4,18,19 This recommendation is
based on the risks of airway obstruction and of malignancy,
the presence of symptoms in the majority of patients on
direct questioning, and the tendency for the goiter to
demonstrate time-dependent progressive growth. Besides,
surgery is associated with low morbidity when performed by
experienced thyroid surgeons.18,19 Nevertheless, contro-
versy exists in surgical treatment of asymptomatic sub-
sternal goiter.19 A large observational study that included
32,777 thyroidectomies (of which 1153 were on substernal
goiter) frommultiple centers within the state of New York in
the United States has convincingly revealed that substernal
thyroidectomy (in comparison with cervical thyroidectomy)
was associated not only with an increased risk of compli-
cations, such as recurrent laryngeal nerve damage (2.1%
vs. 0.6%, respectively), hypoparathyroidism (5.5%vs. 3.5%,
respectively) and postoperative bleeding (2.2% and 0.9%,
respectively), but also with increased mortality (1.4% vs.
0.1%, respectively).20 However, it is generally agreed that
radiologic evidence of significant tracheal narrowing and
potential airway obstruction may be an indication for
surgery in a clinically asymptomatic patient.
7. Surgical approaches and techniques
Surgical removal of a substernal goiter is a challenging
procedure; it can be performed safely via a cervical
approach in most cases (> 90%), with a slightly higher
complication rate than the average rate for cervical goiter
thyroidectomy, especially concerning hypoparathyroidism
and post-operative bleeding.4 The most significant criteria
for selecting patients requiring sternotomy (< 10%) are CT
features, in particular, the presence of an ectopic goiter,
the thyroid gland volume, the extent of the goiter to
or below the tracheal carina, and those suspected of
malignancy.16,21e23
As most substernal goiters are associated with tracheal
deviation and compression, induction of general anesthesia
in such patients has potential hazards. For patients with
compression narrowing of the trachea, we suggest intuba-
tion of the alert patient for bronchoscopic confirmationthat the endotracheal tube is placed distal to the stenotic
area. To avoid traumatic injury of the stenotic trachea,
fiberoptic endobronchial intubation during spontaneous
respiration should be performed under adequate local
anesthesia and sedation.
In our experience,more than 95% of substernal goiters can
be resected via a low transverse incision, particularly in
those with a cervical thyroid mass (secondary type). The
blood supply of secondary substernal goiters almost always
comes from the inferior thyroid vessels. After dissection and
freeing of the cervical portion of the substernal goiter, the
substernal part is easily delivered into the neck with gentle
upward traction of the cervical thyroid and concomitant
finger dissection, starting from the lateral surface, then to
the base of the goiter mass, even if the goiter is so large to
reach the subcarinal level, and even in those with previous
thyroidectomy (recurrent substernal goiter).4 Besides, we
strongly recommend suture obliteration of the substernal
dead space after resection of the goiter mass.
The thoracotomy approaches may result in disastrous
bleeding due to difficulty in controlling the cervical blood
supply in addition to relatively poor identification of the
recurrent laryngeal nerves and the possibility of simulta-
neous removal of the cervical portion of the goiter. On the
other hand, thoracotomy or cervicothoracic or cervicome-
diastinal approaches have been advised when the goiter is
mainly intrathoracic with little or no cervical component
such as ectopic intrathoracic goiter.
8. Surgical results and comorbidity and
mortality
A transverse collar incision is a simple and painless surgical
wound, with much lower morbidity and mortality as
compared with those after thoracotomy or median sternot-
omy approaches.4,19e22 The potential postoperative
complications include vocal cord paralysis, hypoparathy-
roidism, and bleeding. Many authors have reported an inci-
dence of complications after thyroidectomy for substernal
goiters similar to that after standard thyroidectomy (for
cervical goiter), except for postoperative temporary hypo-
parathyroidism.4,12,13,15,18,19 Intraoperative monitoring of
recurrent laryngeal nervemay be helpful in preventing vocal
44 L.-S. Wangcord paralysis. Such hypoparathyroidism occurs more often
in surgery for substernal goiters (5%e10%) than in standard
thyroidectomy.16 Most of patients can leave hospital within
a few days after surgery. Symptoms such as stridor and
dyspnea subside soon after surgery. Despite remarkable
tracheal compression at the time of diagnosis, trache-
omalacia never occurred after thyroidectomy in our previous
experience. Noninvasive positive pressure ventilation may
be used in the management of stridor and airway compro-
mise following early extubation in patients with post-
thyroidectomy tracheomalacia.24 Radiographically, all the
deviated tracheas can resume normal midline position, and
the diameter of the compressed tracheal lumina will
increase to almost normal within 2e3 months after surgery.49. Conclusion
Substernal goiter is diagnosed essentially by chest radiog-
raphy andCT/MRI scans. Surgery for substernal goiters should
always be considered even in elderly patients because of the
high risk of tracheal compression and the low morbidity of
surgery. Most substernal goiters are benign and can be
resected through a cervical approach. Sternotomy or thora-
cotomy is usually needed only in cases of previous cervical
thyroidectomy, invasive carcinoma, or ectopic goiter.References
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